{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T08:48:25Z","timestamp":1772527705104,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Patients with autoimmune diseases can develop multiple autoimmune diseases over a long period of time, and the presence of more than one autoimmune disease in a single patient is defined as polyautoimmunity. Polyautoimmunity may be clinical evidence that autoimmune diseases share similar immunological mechanisms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>We report a 30-year-old woman with a unique combination of autoimmune diseases predominantly affecting the central nervous system, with hypoparathyroidism, hypophysitis, medulla involvement, and pons and temporal lobe involvement associated with primary Sj\u00f6gren's syndrome (pSS), occurring independently over a long period. The patient who had a history of muscle cramps and one seizure incident, presented with vomiting and blurred vision. She was diagnosed with hypophysitis and hypoparathyroidism with calcifications in the basal ganglia and cerebellum. She recovered after four months of corticosteroid treatment for hypophysitis and was started on treatment for hypoparathyroidism. Eight months later, she developed vomiting, hiccups, vertigo, and ataxia with a focal lesion in the medulla. She recovered with immunosuppressive treatment for 2\u00a0years. Fifty-eight months after the onset of hypophysitis, she developed diplopia and dry mouth and eyes. MRI showed infiltrative lesions in the left pons and left temporal lobe. Based on positive anti-Sj\u00f6gren's syndrome-related antigen A antibodies and low unstimulated whole salivary flow rate, pSS was diagnosed. She received corticosteroids and continued mycophenolate mofetil treatment with recovery of neurological symptoms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This case highlights the need for long-term follow-up to detect autoimmune disease processes involving various organs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12883-024-03845-3","type":"journal-article","created":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T23:44:28Z","timestamp":1726098268000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Hypophysitis and central nervous system involvement in association with Sj\u00f6gren\u2019s syndrome along with hypoparathyroidism: a case report"],"prefix":"10.1186","volume":"24","author":[{"given":"Jungyon","family":"Yum","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumie","family":"Rhee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyoung","family":"Heo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,12]]},"reference":[{"issue":"6","key":"3845_CR1","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/ar3175","volume":"12","author":"JM Anaya","year":"2010","unstructured":"Anaya JM. The autoimmune tautology. Arthritis Res Ther. 2010;12(6):147.","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"3845_CR2","first-page":"132","volume":"5","author":"M Cojocaru","year":"2010","unstructured":"Cojocaru M, Cojocaru IM, Silosi I. Multiple autoimmune syndrome. Maedica (Bucur). 2010;5(2):132\u20134.","journal-title":"Maedica (Bucur)"},{"key":"3845_CR3","first-page":"254319","volume":"2012","author":"A Rojas-Villarraga","year":"2012","unstructured":"Rojas-Villarraga A, Amaya-Amaya J, Rodriguez-Rodriguez A, et al. Introducing polyautoimmunity: secondary autoimmune diseases no longer exist. Autoimmune Dis. 2012;2012:254319.","journal-title":"Autoimmune Dis"},{"issue":"4","key":"3845_CR4","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s40618-022-01994-1","volume":"46","author":"C Betterle","year":"2023","unstructured":"Betterle C, Furmaniak J, Sabbadin C, et al. Type 3 autoimmune polyglandular syndrome (APS-3) or type 3 multiple autoimmune syndrome (MAS-3): an expanding galaxy. J Endocrinol Invest. 2023;46(4):643\u201365.","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"3845_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1136\/annrheumdis-2016-210571","volume":"76","author":"CH Shiboski","year":"2017","unstructured":"Shiboski CH, Shiboski SC, Seror R, et al. 2016 American College of Rheumatology\/European League Against Rheumatism classification criteria for primary Sjogren\u2019s syndrome: a consensus and data-driven methodology involving three international patient cohorts. Ann Rheum Dis. 2017;76(1):9\u201316.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"3845_CR6","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1210\/jc.2003-031054","volume":"89","author":"O Kifor","year":"2004","unstructured":"Kifor O, McElduff A, LeBoff MS, et al. Activating antibodies to the calcium-sensing receptor in two patients with autoimmune hypoparathyroidism. J Clin Endocrinol Metab. 2004;89(2):548\u201356.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"3845_CR7","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1093\/rheumatology\/ker128","volume":"50","author":"HE Harris","year":"2011","unstructured":"Harris HE, Kemp EH, Brown EM, Weetman AP, Swaminathan K. First report of anti-calcium-sensing receptor antibodies in a patient with Sjogren\u2019s syndrome and primary hypoparathyroidism. Rheumatology (Oxford). 2011;50(6):1173\u20135.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"3845_CR8","doi-asserted-by":"publisher","first-page":"17055","DOI":"10.1038\/nrdp.2017.55","volume":"3","author":"M Mannstadt","year":"2017","unstructured":"Mannstadt M, Bilezikian JP, Thakker RV, et al. Hypoparathyroidism. Nat Rev Dis Primers. 2017;3(1):17055.","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"3845_CR9","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s40618-020-01355-w","volume":"44","author":"G Zavatta","year":"2021","unstructured":"Zavatta G, Clarke BL. Basal ganglia calcification in hypoparathyroidism and pseudohypoparathyroidism: local and systemic metabolic mechanisms. J Endocrinol Invest. 2021;44(2):245\u201353.","journal-title":"J Endocrinol Invest"},{"issue":"6","key":"3845_CR10","doi-asserted-by":"publisher","first-page":"5917","DOI":"10.3390\/ijms24065917","volume":"24","author":"CA Rawanduzy","year":"2023","unstructured":"Rawanduzy CA, Winkler-Schwartz A, Couldwell WT. Hypophysitis: defining histopathologic variants and a review of emerging clinical causative entities. Int J Mol Sci. 2023;24(6):5917.","journal-title":"Int J Mol Sci."},{"issue":"13","key":"3845_CR11","doi-asserted-by":"publisher","first-page":"e3132","DOI":"10.1097\/MD.0000000000003132","volume":"95","author":"C Louvet","year":"2016","unstructured":"Louvet C, Maqdasy S, Tekath M, et al. Infundibuloneurohypophysitis associated with sjogren syndrome successfully treated with mycophenolate mofetil: a case report. Medicine (Baltimore). 2016;95(13):e3132.","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"3845_CR12","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s11102-016-0736-z","volume":"19","author":"G Bellastella","year":"2016","unstructured":"Bellastella G, Maiorino MI, Bizzarro A, et al. Revisitation of autoimmune hypophysitis: knowledge and uncertainties on pathophysiological and clinical aspects. Pituitary. 2016;19(6):625\u201342.","journal-title":"Pituitary"},{"issue":"2","key":"3845_CR13","doi-asserted-by":"publisher","first-page":"99","DOI":"10.5114\/reum.2018.75521","volume":"56","author":"J Perzynska-Mazan","year":"2018","unstructured":"Perzynska-Mazan J, Maslinska M, Gasik R. Neurological manifestations of primary Sjogren\u2019s syndrome. Reumatologia. 2018;56(2):99\u2013105.","journal-title":"Reumatologia"},{"key":"3845_CR14","first-page":"645967","volume":"2012","author":"GJ Tobon","year":"2012","unstructured":"Tobon GJ, Pers JO, Devauchelle-Pensec V, Youinou P. Neurological disorders in primary Sjogren\u2019s syndrome. Autoimmune Dis. 2012;2012:645967.","journal-title":"Autoimmune Dis"},{"issue":"4","key":"3845_CR15","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.rdc.2017.06.002","volume":"43","author":"M Margaretten","year":"2017","unstructured":"Margaretten M. Neurologic manifestations of primary sjogren syndrome. Rheum Dis Clin North Am. 2017;43(4):519\u201329.","journal-title":"Rheum Dis Clin North Am"},{"issue":"8","key":"3845_CR16","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1093\/rheumatology\/keq111","volume":"49","author":"A Massara","year":"2010","unstructured":"Massara A, Bonazza S, Castellino G, et al. Central nervous system involvement in Sjogren\u2019s syndrome: unusual, but not unremarkable\u2013clinical, serological characteristics and outcomes in a large cohort of Italian patients. Rheumatology (Oxford). 2010;49(8):1540\u20139.","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"3845_CR17","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00296-014-3097-9","volume":"35","author":"I Moreira","year":"2015","unstructured":"Moreira I, Teixeira F, Martins Silva A, et al. Frequent involvement of central nervous system in primary Sjogren syndrome. Rheumatol Int. 2015;35(2):289\u201394.","journal-title":"Rheumatol Int"},{"issue":"1","key":"3845_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/annrheumdis-2019-216114","volume":"79","author":"M Ramos-Casals","year":"2020","unstructured":"Ramos-Casals M, Brito-Zeron P, Bombardieri S, et al. EULAR recommendations for the management of Sjogren\u2019s syndrome with topical and systemic therapies. Ann Rheum Dis. 2020;79(1):3\u201318.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"3845_CR19","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s40618-017-0740-9","volume":"41","author":"GJ Kahaly","year":"2018","unstructured":"Kahaly GJ, Frommer L. Polyglandular autoimmune syndromes. J Endocrinol Invest. 2018;41(1):91\u20138.","journal-title":"J Endocrinol Invest"},{"issue":"5","key":"3845_CR20","doi-asserted-by":"publisher","first-page":"e228634","DOI":"10.1136\/bcr-2018-228634","volume":"12","author":"K Iizuka","year":"2019","unstructured":"Iizuka K, Mizuno M, Nonomura K, Yabe D. A rare case of autoimmune polyglandular syndrome with Sjogren\u2019s syndrome and primary hypoparathyroidism. BMJ Case Rep. 2019;12(5):e228634.","journal-title":"BMJ Case Rep."}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-024-03845-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-024-03845-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-024-03845-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T23:44:56Z","timestamp":1726098296000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-024-03845-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,12]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3845"],"URL":"https:\/\/doi.org\/10.1186\/s12883-024-03845-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4203233\/v1","asserted-by":"object"}]},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,12]]},"assertion":[{"value":"2 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Yonsei University Health System, Institutional Review Board (Y-2023-0713), and the patient gave written informed consent prior to obtain the data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this Case report. A copy of the written consent is available for review by the Editor of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"339"}}